GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patientsLihua Yu, Lihua Yang, Jiale Liu et al.|Journal of Cancer Research and Clinical Oncology|2021Cited by 84
Dual-crosslinking immunostimulatory hydrogel synchronously suppresses pancreatic fistula and pancreatic cancer relapse post-resectionRuizhi Zhao, Chihua Fang, Qiuqun Xiao et al.|Biomaterials|2023Cited by 27
GD2-specific Chimeric Antigen Receptor-modified T Cells for the treatment of Refractory and/or Recurrent Neuroblastoma in Pediatric PatientsLihua Yu, Lihua Yang, Lulu Huang et al.|Research Square|2021Cited by 7